Article
A Novel Radio-Genomics Biomarker for Precision Epidermal Growth Factor Receptor Mutation Targeting Therapy in Non-Small Cell Lung Cancer
2025-05-07
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Newer generation tyrosine kinase inhibitors (TKI) are becoming more effective against cancers exhibiting certain driver mutations, with those relating to epidermal growth factor receptor (EGFR) being the mostly commonly targeted in non-small cell lung cancer (NSCLC). Treatment decision is currently guided by tissue sampling and genetic testing, an invasive...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a0034b88-63d0-50f6-b8e2-94bb67e89324
- DOI
- 10.21203/rs.3.rs-6396507/v1
